Guides ARV regimen selection based on resistance testing, prior therapy, HLA-B*5701 status, and renal function. Preferred first-line: bictegravir/tenofovir AF/emtricitabine or dolutegravir + tenofovir/emtricitabine.
Use the full interactive calculator below, or